Structuring the review of human genetics protocols. Part III: Gene therapy studies

IRB Ethics and Human Research

Volumn 21, Issue 2, 1999, Pages 1-9

  Glass, Kathleen Cranley ^a,b,c   Weijer, Charles ^d,e   Cournoyer, Denis ^b   Lemmens, Trudo ^e,f,g   Palmour, Roberta M ^b   Shapiro, Stanley H ^b,e   Freedman, Benjamin ^e,h,i  

^a Depts of Hum Genet and Pediatrics

^b MCGILL UNIVERSITY   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d DALHOUSIE UNIVERSITY   (Canada)

^e CTRG ^*

^f CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h MCGILL UNIVERSITY   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; ETHICS; GENE THERAPY; GENETIC ENGINEERING; GENETIC ENHANCEMENT; GENETICS AND REPRODUCTION; GERM CELL; HUMAN; HUMAN EXPERIMENT; INFORMED CONSENT; METHODOLOGY; NOMENCLATURE; PROFESSIONAL STANDARD; RISK; RISK ASSESSMENT; TECHNIQUE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

ETHICAL REVIEW; ETHICS; ETHICS COMMITTEES; ETHICS COMMITTEES, RESEARCH; GENE THERAPY; GENETIC ENGINEERING; GENETIC ENHANCEMENT; GERM CELLS; HUMAN EXPERIMENTATION; HUMANS; INFORMED CONSENT; METHODS; RESEARCH DESIGN; RISK; RISK ASSESSMENT; TERMINOLOGY;

EID: 0033085928     PISSN: 01937758     EISSN: None     Source Type: Journal    
DOI: 10.2307/3563776     Document Type: Review

References (59)

1. Glass KC, Weijer C, Palmour RA, Shapiro S, Lemmens T, Lebacqz K. Structuring the review of human genetics protocols: gene localization and identification studies. IRB 1996; 18(4): 1-9.
2. Glass KC, Weijer C, Lemmens TM, Palmour RA, Shapiro S. Structuring the review of human genetics protocols: genetic diagnostic and screening studies. IRB 1997; 19(3,4): 1-13.
3. Wivel NA. Clinical overview of human gene transfer trials. In Scientific Summary Report: Gene Delivery Systems, A State-of-the-Art Review, Paris: Organization for Economic Co-operation and Development, 1995: 19-27.
4. Sikora K. Clinical gene delivery. In Gene Delivery Systems, A State of the Art Review, 1995.
5. Walters L, Palmer JG. The Ethics of Human Gene Therapy. Appendix C: Additional Methods for Delivering Genes to Cells. New York: Oxford University Press, 1997.
6. Dubé ID, Cournoyer D. Gene therapy: here to stay. Canadian Medical Association Journal 1995; 152:1605-13.
7. Freidmann T. Progress toward human gene therapy. Science 1989; 244:1277.
8. King RC, Stansfield A. A Dictionary of Genetics, 4th ed. New York: Oxford University Press, 1990.
9. See note 3, Wivel 1995.
10. See note 4, Walters, Palmer 1997.
11. See note 4, Walters, Palmer 1997; see also Friedman T. Overcoming the obstacles to gene therapy. Scientific American 1997; June: 96-101.
12. See note 11, Friedman 1997; Conference Proceedings: Gene Therapy: The Next Generation, October 1-3, 1997. Centre Hospitalier et Universitaire Cochin Port-Royal, Paris.
13. See note 1, Glass et al. 1996; note 2, Glass et al. 1997.
14. NIH Guidelines, Appendix M. The Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into the Genome of One or More Human Subjects (Points to Consider), 1991, as amended.
15. Medical Research Council of Canada. Research on Gene Therapy in Humans: Background and Guidelines [discussion paper]. Ottawa: MRC, 1989.
16. Royal Commission on New Reproductive Technologies. Proceed With Care. Ottawa: Minister of Government Services, 1993.
17. Wertz DC, et al. Guidelines on Ethical Issues in Medical Genetics and the Provision of Genetic Services. Geneva: World Health Organization, 1995.
18. See note 15, Medical Research Council 1989; note 16, Royal Com-mission 1993.
19. Law on scientific ethical committee and the handling of biomedical research projects, Law No. 503 of June 24, 1992 (Denmark); Code de la santé publique, Art.L. 209-11 (France).
20. 45 CFR 46; Medical Research Council of Canada, Guidelines for Research on Somatic Cell Gene Therapy in Humans. Ottawa: Minister of Supply and Services, Canada, 1990.
21. Walters L. Genetics and reproductive technologies. In: Medical Ethics, ed. Veatch RM. Boston: Jones and Bartlett, 1989: 201-8; see note 20, Medical Research Council 1990.
22. Anderson WF, Friedmann T. Strategies for gene therapy. In: Encyclopedia of Bioethics, ed. Reich WT. New York: Simon & Schuster MacMillan, 1995: 907-14.
23. Kessler DA, Siegel JP, Noguchi PD, Zoon KC, Feiden KL, Woodcock J. Regulation of somatic-cell therapy and gene therapy by the Food and Drug Administration. NEJM 1993; 329: 1169-73.
24. See note 20, Medical Research Council 1990.
25. See note 23, Kessler et al. 1993; Food and Drug Administration. Addendum to the points to consider in human somatic cell and gene therapy (1991). Human Gene Therapy 1996; 7: 1181-90.
26. Knowles MR, Hohneker KW, Zhou Z, et al. A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. NEJM 1995; 333: 823-31.
27. Wilson JM: Adenoviruses as gene-delivery vehicles. NEJM 1996; 334: 1185-7.
28. Leiden JM. Gene therapy - promise, pitfalls, and prognosis. NEJM 1995; 333: 871-3; Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. NEJM 1995; 333: 832-8.
29. Leiden JM. Gene therapy - promise, pitfalls, and prognosis. NEJM 1995; 333: 871-3; Mendell JR, Kissel JT, Amato AA, et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. NEJM 1995; 333: 832-8.
30. See note 7, Friedman 1989.
31. Crystal RG. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 270: 404-9; See note 22, Anderson, Friedman 1995.
32. Ledley D: After gene therapy: issues in long-term clinical follow-up and care. Advances in Genetics 1995; 333: 871-3.
33. See note 21, Walters 1989.
34. See note 30, Crystal 1995.
35. See note 20, Medical Research Council 1990.
36. See note 20, Medical Research Council 1990.
37. Rifkin JJ. Algeny. Viking Press: New York, 1983; Walters L, Palmer JG. The Ethics of Human Gene Therapy. New York: Oxford University Press, 1997.
38. Rifkin JJ. Algeny. Viking Press: New York, 1983; Walters L, Palmer JG. The Ethics of Human Gene Therapy. New York: Oxford University Press, 1997.
39. Kramer PD. Listening to Prozac. New York: Penguin, 1993.
40. Capron AM. Grandma? No, I'm the mother. Hastings Center Report 1994; 24(2): 24-5; See note 16, Royal Commission 1993.
41. Allen DB, Fost NC. Growth hormone therapy for short stature: panacea or Pandora's box? Bioethics News 1991; 10(4); 25-34.
42. Parens E. Taking behavioral genetics seriously. Hastings Center Report 1996; 26(4):13-8.
43. Anderson WF. Human gene therapy: why draw a line? Journal of Medicine and Philosophy 1989; 14:681-3.
44. Whitehouse PJ, Juengst E, Mehlman M, Murray TH. Enhancing cognition in the intellectually intact. Hastings Center Report 1997; 27(3): 14-22.
45. President's Commission for the Study of Ethical Issues in Medicine and Biomedical and Behavioral Research, Splicing Life: The Social and Ethical Issues of Genetic Engineering with Human Beings. Washington, D.C.: U.S. Government Printing Office, 1982.
46. 45 CFR 46.111a(2); Levine R.J. Ethics and Regulation of Clinical Research, 2nd ed. New Haven: Yale University Press, 1988.
47. Marshall E. Varmus proposes to scrap the RAC. Science 1996; 272: 1569-70.
48. See note 16, Royal Commission 1993.
49. See note 5, Walters, Palmour 1997.
50. Knoppers BM, Chadwick R. The Human Genome Project under an international microscope. Science 1994; 265:2035-6.
51. McCormick R. How brave a new world. Current Theology 1969; January-June: 635-92.
52. Ramsey P. Ethics at the Edges of Life. New Haven: Yale University Press, 1978; Kass L.R. Toward a More Natural Science. New York: The Free Press, 1986.
53. Ramsey P. Ethics at the Edges of Life. New Haven: Yale University Press, 1978; Kass L.R. Toward a More Natural Science. New York: The Free Press, 1986.
54. See note 48, Knoppers 1994.
55. Gustavson JM. A Christian perspective on genetic engineering. Human Gene Therapy 1994; 5:747-54.
56. Fletcher J, Anderson WF. Germline gene therapy: a new stage of debate. Law, Medicine & Health Care 1992; 20(1-2):26-38.
57. Krimsky S. Biotechnics and Society: The Rise of Industrial Genetics. New York: Praeger, 1992.
58. See note 50, Ramsey 1978, Kass, 1985; see note 52, Gustavson 1994.
59. Krimsky S. Human gene therapy: must we know where to stop before we start? Human Gene Therapy 1990; 1:171-3.